| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |